Patient P-03432
Therapy response
Declining
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
51%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S19
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+24
- Inflammatory activity+9
- Nutritional resilience-8
- Treatment adherence+7
What helped?
No interventions yet.
LIFE OS recommendation
Monitoring Escalation ME-01
77%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 100% showed improvement
- median effect visible after 3 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log4.2/10
worsening · -0.6 vs previous 14 d
Stress level
Daily log4.3/10
worsening · +0.7 vs previous 14 d
Pessimism score
Daily log4.2/10
worsening · +0.6 vs previous 14 d
Sleep quality
Wearable24.8/100
worsening · -8.2 vs previous 14 d
Libido
Daily log4.1/10
worsening · -0.6 vs previous 14 d
HRV
Wearable43.7 ms
stable · -1.6 vs previous 14 d
Toxicity
Blood23.8/100
worsening · +3.1 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 59 from the failing basin, 30 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -6.2 next day on high-intake days · n 24
Would not help
- AD-05 Adherence Supportonly 31% improved among 13 similar
- Keep caffeine lowGI +5.4 next day on high-intake days · n 16
- Keep lactose lowGI +3.6 next day on high-intake days · n 17
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-6.2supporter · 95%
- Caffeine+5.4detractor · 95%
- Lactose+3.6detractor · 91%
- Alcohol+0.5no signal · 15%
- Dietary fat load+0.4no signal · 15%
- Histamine load+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
- Autonomic recovery ↓20
- WearableShort sleep window
- Mucosal barrier integrity ↓10
- WearableSleep 5.6 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- CYP2D6 Poor metabolizerHigher exposure at standard dose
Microbiome
Shannon diversity 4.4 · butyrate capacity 72/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 43 ms
- Sleep
- 6.5 h
- Steps
- 7,052
- Resting HR
- 66 bpm
Daily log: GI score 33, nutritional resilience 60, adherence 94.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-03178 | 54% | S11 | GI-04 | improved | 54 |
| P-03374 | 51% | S19 | ME-01 | improved | 55 |
| P-03252 | 44% | S13 | SC-12 | improved | 68 |
| P-03057 | 43% | S14 | NP-02 | improved | 64 |
| P-03179 | 42% | S05 | GI-04 | improved | 52 |
| P-03144 | 41% | S16 | HY-01 | improved | 52 |
| P-03255 | 41% | S01 | HY-01 | improved | 53 |
| P-03204 | 39% | S16 | AD-05 | improved | 48 |
| P-03208 | 39% | S02 | BR-03 | improved | 57 |
| P-03375 | 38% | S09 | DT-01 | improved | 52 |
| P-03484 | 38% | S07 | DT-01 | improved | 49 |
| P-03244 | 37% | S08 | DT-01 | improved | 53 |